Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the ten analysts that are presently covering the company, Marketbeat reports. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price target among brokers that have covered the stock in the last year is $86.67.
Several brokerages recently commented on ACHC. KeyCorp started coverage on Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Deutsche Bank Aktiengesellschaft increased their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Barclays reduced their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research note on Monday, September 30th. Cantor Fitzgerald restated a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, October 1st. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a research note on Friday, September 20th.
Read Our Latest Stock Analysis on Acadia Healthcare
Institutional Inflows and Outflows
Acadia Healthcare Stock Down 12.3 %
ACHC stock opened at $52.03 on Friday. The company has a 50 day moving average of $70.74 and a two-hundred day moving average of $69.51. The company has a market cap of $4.83 billion, a price-to-earnings ratio of -371.64, a PEG ratio of 1.57 and a beta of 1.29. Acadia Healthcare has a 12-month low of $51.07 and a 12-month high of $87.77. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The firm had revenue of $796.00 million during the quarter, compared to analysts’ expectations of $784.38 million. During the same quarter last year, the firm earned $0.92 earnings per share. The business’s revenue for the quarter was up 8.8% on a year-over-year basis. On average, equities analysts anticipate that Acadia Healthcare will post 3.51 earnings per share for the current fiscal year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- What is the Dogs of the Dow Strategy? Overview and Examples
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- 3 Tickers Leading a Meme Stock Revival
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.